SLC5A2 and acute myocardial infarction: In diabetic patients with acute myocardial infarction undergoing coronary angioplasty (SGLT2-i AMI Project Registry), the incidence of contrast-induced AKI was 5.4% in those patients using SGLT2 inhibitors (versus 13.1%, p = 0.022), with creatinine levels being significantly lower at 72 hours after contrast use37.